Strata Skin's Shares Plummet as Laseroptek Files Counterclaims for Unfair Business Practices
ByAinvest
Thursday, Feb 12, 2026 9:41 am ET1min read
SSKN--
Strata Skin Sciences shares have plummeted 60% in pre-market trading after Laseroptek America filed counterclaims and third-party claims against the company and its CEO. Laseroptek alleges unfair competition, anticompetitive practices, and defamation. The counterclaims dispute reimbursement codes, product performance comparisons, and patent misrepresentations. Strata Skin markets XTRAC lasers, VTRAC lamp systems, and TheraClearX Acne Therapy System. The stock is currently trading at $0.46, down 61.61%.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet